A brand of pharma startup Zeno Health, the new drug will be made available across all local stores by end of Q4

Zeno Health India’s leading omni-channel platform for quality and affordable generic medicines, under the brand name GoodAid unveiled a insulin product at the most competitive price point. Through this new product, it aims to provide a cost-effective solution for diabetes management. The startup is also planning to make the product available across all local stores in Maharashtra, West Bengal and thereby expanding its customer base in other states of India in the next 3 years.

Speaking at the occasion, Siddharth Gadia, Co-Founder, of GoodAid & Zeno Health said, “According to WHO’s survey the alarming number of cases of diabetic patients registered in India is just a fraction of the total number of affected patients. The ever-increasing medical expense is one of the reasons why many patients avoid testing to detect the disease in the first place. At Zeno Health we are dedicated to offering affordable medications to all, aiming to alleviate the burden of medical costs, and have successfully reduced the cost of medicines for our patrons. Our research and development team at GoodAid is tirelessly working on finding solutions for various chronic diseases, with diabetes being one of them. Through this new product, we are honoring our commitment to our fellow citizens.”

Diabetes is a chronic health issue that emerges when the pancreas is unable to produce an adequate amount of insulin, or when the body fails to use the insulin it has synthesized effectively. GoodAid had recently surveyed its customers to understand their requirements for an insulin product. Through the survey, the company found out that more than 50% of customers favored a cost-effective solution for insulins. With the need to create an impact among their customers in terms of savings, GoodAid decided to launch a new insulin product. The insulins are available across all 180+ Zeno Health stores in Mumbai and Pune and will be available at local stores by the end of this financial year.

GoodAid was established to address the issues of Authenticity, Availability, and Affordability in the pharmaceutical sector. Over the last three years, the company has introduced over 350 product lines spanning 18 therapeutic areas, such as cardiology and diabetes, and has made them available in various forms, including tablets and capsules.